Skip to main content

A Study Describing Scratch and Sleep Patterns in Patients With Primary Biliary Cholangitis (Luminaria)

Completed · NCT07049887

Conditions: Primary Biliary Cholangitis

At a glance

Research payments reported, 2025
$124,082
U.S. investigators named
3
Sites paid
4
Planned or actual enrollment
30

About the trial

Sponsor
Ipsen
Dates
Started 2025-07-16; completion 2026-02-23
Results posted
Not yet

This study will collect information from patients with Primary Biliary Cholangitis (PBC). PBC is a progressive rare liver disease in which tubes in the liver called bile ducts are damaged. The liver damage in PBC may lead to scarring (cirrhosis). People living with PBC often face challenges like intense itching, trouble sleeping, and feeling constantly tired. These symptoms can make it hard for them to enjoy daily life and feel well overall. While itching and sleep patterns can be difficult to measure accurately based on recall and may lack precision, the main aim of this study is to use a digital health tool to assess the severity of itchiness and sleep patterns in people with PBC. The t…

From ClinicalTrials.gov, last updated 2026-04-30. Full record, eligibility and contacts (opens in a new tab)

Industry funding

Ipsen Biopharmaceuticals, Inc reported $124,082 in research payments for this study in 2025 (31 payments).

Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.

U.S. investigators named on this study

Clinicians the company named as principal investigators in its Open Payments reports.

Sites paid to run it

  • Arizona Clinical Trials $42,994
  • University of Miami $34,367
  • Arizona Liver Health $25,091
  • University of Texas Southwestern Medical School $21,631

Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.